Condition
Newly Diagnosed Multiple Myeloma clinical trials and research
Research outlook What's coming for Multiple myeloma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 5 Newly Diagnosed Multiple Myeloma clinical trials that are recruiting, at sites in 26 countries (most in Germany (3), Spain (3), Australia (2)). By phase: Phase 3 (3), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 26Countries
Newest Newly Diagnosed Multiple Myeloma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| AZD0120 added to induction in multiple myeloma patients ineligible for stem cell transplant | Phase 3 | Gilbert, Arizona and 123 other locations | Recruiting | Aug 14, 2026 |
| Switching to Carfilzomib for Patients Intolerant to Bortezomib in Multiple Myeloma | — | Suzhou, Jiangsu | Recruiting | Nov 12, 2024 |
| Comparing two treatment combinations for newly diagnosed multiple myeloma patients who can't undergo stem cell transplantation | Phase 3 | Mobile, Alabama and 180 other locations | Recruiting | Nov 7, 2024 |
| New treatment approach for newly diagnosed multiple myeloma patients | Phase 2/3 | Berlin and 5 other locations | Recruiting | Dec 27, 2022 |
| Extended VRD plus vs Isa-VRD vs Isa-V-Iberdomide as part of ASCT in newly diagnosed multiple myeloma | Phase 3 | Alcalá de Henares, Madrid and 67 other locations | Recruiting | Sep 28, 2022 |
All recruiting trials (5)
-
AZD0120 added to induction in multiple myeloma patients ineligible for stem cell transplant
In people with newly diagnosed multiple myeloma who can’t have a stem cell transplant, this study tests whether a single dose of AZD0120 after standard induction therapy helps more than continuing the standard therapy.
-
Switching to Carfilzomib for Patients Intolerant to Bortezomib in Multiple Myeloma
This study is testing if switching to a new treatment called carfilzomib helps Chinese patients with multiple myeloma who can't tolerate their previous bortezomib therapy feel better and live longer.
-
Comparing two treatment combinations for newly diagnosed multiple myeloma patients who can't undergo stem cell transplantation
This study is testing if a new combination of medications can help people with newly diagnosed multiple myeloma who can't have a stem cell transplant live longer without their disease getting worse compared to a different treatment combination.
-
New treatment approach for newly diagnosed multiple myeloma patients
This study is testing a new combination of treatments for people who have just been diagnosed with multiple myeloma to see if it can help them do better and feel less sick during their care.
-
Extended VRD plus vs Isa-VRD vs Isa-V-Iberdomide as part of ASCT in newly diagnosed multiple myeloma
This trial tests three treatment approaches added to autologous stem cell transplant to see which best clears disease in newly diagnosed myeloma.
Related topics
Quick answers
How many Newly Diagnosed Multiple Myeloma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 26 countries. The most sites are in Germany (3 trials), Spain (3 trials), Australia (2 trials), Brazil (2 trials), Canada (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 3, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.